ClinConnect ClinConnect Logo
Search / Trial NCT03544489

Effectiveness of Exercise After an ICD

Launched by UNIVERSITY OF WASHINGTON · May 21, 2018

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a specific exercise program for people who have had an implantable cardioverter defibrillator (ICD) placed in their heart. An ICD is a device that helps prevent sudden cardiac arrest by delivering shocks to the heart if it detects dangerous rhythms. The goal of the study is to see if participating in this exercise program can improve the health and well-being of ICD users.

To be eligible for the trial, participants need to be at least 18 years old and have received an ICD for either preventing a heart problem or because they already experienced one. They should be able to walk on their own for a short time each day, understand and communicate in English, and have a phone to stay in touch for six months. However, individuals with certain serious health issues, recent heart problems, or who are pregnant cannot participate. If you join the study, you can expect to engage in a guided exercise program while contributing to important research that could help others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ICD implantation for primary or secondary prevention of sudden cardiac arrest, -ability to read, speak and write English,-
  • access to a reliable phone for 6 months after study entry,
  • able to ambulate without assist devices for at least 5-10 minutes/day
  • greater than 18 years of age.
  • Exclusion Criteria:
  • current diagnosis of serious mental disorder,
  • regular non-medical use of illicit drugs (opiates, cocaine, amphetamines, etc.), -unstable angina, myocardial infarction, ICD shock or heart surgery within previous 3 months
  • pregnancy
  • concurrent participation in an exercise program \> 5 days/week.

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Cynthia M Dougherty, ARNP, PhD

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials